DexCom, Inc. (DXCM)

業務介紹

DexCom, Inc.是一家醫療器械公司，專注於設計、開發和商業化連續葡萄糖監測（CGM）系統，產品遍及美國和國際市場。該公司提供的系統供糖尿病患者和醫療保健提供者使用。其產品包括DexCom G6，一種用於糖尿病管理的集成CGM系統；Dexcom Real-Time API，使受邀的第三方開發人員能夠將實時CGM數據集成到其數字健康應用程序和設備中；Dexcom ONE，旨在取代糖尿病治療決策中的針刺血糖測試；以及Dexcom Share，一種遠程監測系統。該公司的產品候選包括Dexcom G7，一種下一代G7 CGM系統。DexCom, Inc.與Verily Life Sciences LLC和Verily Ireland Limited簽訂了合作和許可協議，共同開發基於血液或間質葡萄糖監測的產品。該公司直接將其產品銷售給內分泌學家、醫生和糖尿病教育者。DexCom, Inc.成立於1999年，總部位於加利福尼亞州聖地亞哥。

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

公司網址

https://www.dexcom.com